Aemetis’ (AMTX) “Buy” Rating Reaffirmed at HC Wainwright

Aemetis (NASDAQ:AMTX)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a research report issued to clients and investors on Friday,Benzinga reports. They currently have a $28.00 target price on the specialty chemicals company’s stock.

Separately, StockNews.com raised shares of Aemetis to a “sell” rating in a report on Wednesday, February 5th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, Aemetis has a consensus rating of “Hold” and a consensus target price of $14.56.

Aemetis Price Performance

Shares of AMTX stock opened at $1.59 on Friday. The stock’s fifty day moving average price is $2.23 and its 200 day moving average price is $2.68. Aemetis has a 1-year low of $1.56 and a 1-year high of $7.03. The company has a market cap of $81.33 million, a price-to-earnings ratio of -0.70 and a beta of 1.48.

Hedge Funds Weigh In On Aemetis

Several large investors have recently made changes to their positions in the company. Price T Rowe Associates Inc. MD raised its position in shares of Aemetis by 16.1% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 38,016 shares of the specialty chemicals company’s stock worth $103,000 after acquiring an additional 5,281 shares during the period. Tower Research Capital LLC TRC increased its stake in shares of Aemetis by 128.8% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,407 shares of the specialty chemicals company’s stock valued at $28,000 after purchasing an additional 5,859 shares in the last quarter. Barclays PLC increased its stake in shares of Aemetis by 14.7% in the 4th quarter. Barclays PLC now owns 54,492 shares of the specialty chemicals company’s stock valued at $146,000 after purchasing an additional 6,996 shares in the last quarter. Wells Fargo & Company MN raised its holdings in Aemetis by 20.0% in the 4th quarter. Wells Fargo & Company MN now owns 45,741 shares of the specialty chemicals company’s stock worth $123,000 after purchasing an additional 7,622 shares during the period. Finally, FMR LLC boosted its position in Aemetis by 68.2% during the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after purchasing an additional 9,137 shares in the last quarter. 27.02% of the stock is currently owned by institutional investors and hedge funds.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.